Skip to Content

Drug Interactions between fexofenadine / pseudoephedrine and trichophyton skin test

This report displays the potential drug interactions for the following 2 drugs:

  • fexofenadine/pseudoephedrine
  • trichophyton skin test

Edit list (add/remove drugs)

Interactions between your drugs


fexofenadine trichophyton skin test

Applies to: fexofenadine / pseudoephedrine and trichophyton skin test

Fexofenadine may interfere with your response to trichophyton skin test. If you are currently using or have recently used fexofenadine, let your doctor know before you get tested with trichophyton skin test. It is generally best to discontinue fexofenadine for 2 to 4 days before testing, but you should check with your doctor. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions


fexofenadine food

Applies to: fexofenadine / pseudoephedrine

Consuming large amounts of certain fruit juices, including grapefruit, orange and apple, may decrease the levels of fexofenadine in your body. Fexofenadine should be taken with water and refrain from drinking large amounts of grapefruit, orange, or apple juice. This will make it easier for your body to absorb the medication.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.